Severe acute neurotoxicity reflects absolute intra-carotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine dose in non-human primates
Open Access
- 9 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 366, 109406
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Low nigrostriatal reserve for motor parkinsonism in nonhuman primatesExperimental Neurology, 2012
- No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson DiseasePLOS ONE, 2012
- The therapeutic potential of monoamine oxidase inhibitorsNature Reviews Neuroscience, 2006
- Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonismExperimental Neurology, 2005
- Investigation of the functional effect of monoamine oxidase polymorphisms in human brainHuman Genetics, 2001
- Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegilineJournal of Neural Transmission, 2001
- Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeysNeurobiology of Aging, 1995
- MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeysAnnals of Neurology, 1994
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983